ArticleThe Pan African medical journal2025
Advancing vaccine manufacturing in Africa: a new era for immunisation programmes towards self-sufficiency.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Vaccine equity in Africa: a rapid review of policy, legal and governance frameworks to improve research and development.Frontiers in health services · 2026Pooled it
- Can a sovereign health research culture bolster Africa's involvement in global health?Global health action · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite Africa's impressive vaccination coverage gains over the previous half-century, the continent's reliance on imported vaccines revealed significant weaknesses in disease control, especially during the COVID-19 pandemic. Establishing a strong and long-lasting vaccine manufacturing infrastructure throughout the continent is essential to achieving health sovereignty and security. The prospects, difficulties, and tactical measures needed to improve vaccine manufacturing in Africa are highlighted in this commentary. Investing in capacity building to create industrial clusters, bolstering regulatory frameworks, and utilizing public-private partnerships are important components. The Partnerships for African Vaccine Manufacturing (PAVM), spearheaded by Africa CDC and the World Health Organization (WHO) support offer blueprints for progress as well as guidelines for advancement. Improving immunisation programmes and getting ready for future public health emergencies depend heavily on achieving vaccine self-sufficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.